Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Engineering the mouse genome to model human disease for drug discovery.

Koentgen F, Suess G, Naf D.

Methods Mol Biol. 2010;602:55-77. doi: 10.1007/978-1-60761-058-8_4.

PMID:
20012392
2.

Genetic engineering in the mouse: tuning TNF/TNFR expression.

Douni E, Alexiou M, Kollias G.

Methods Mol Med. 2004;98:137-70.

PMID:
15064438
3.

Genetically engineered mouse models in drug discovery research.

Sacca R, Engle SJ, Qin W, Stock JL, McNeish JD.

Methods Mol Biol. 2010;602:37-54. doi: 10.1007/978-1-60761-058-8_3.

PMID:
20012391
4.

Engineering chromosomal rearrangements in mice.

Yu Y, Bradley A.

Nat Rev Genet. 2001 Oct;2(10):780-90. Review.

PMID:
11584294
5.
6.

[Application and recent advances of laboratory mouse in human cancer research].

Liu EQ, Kitajima S, Morimoto M.

Ai Zheng. 2005 Feb;24(2):249-54. Review. Chinese.

PMID:
15694046
7.

Genome engineering via homologous recombination in mouse embryonic stem (ES) cells: an amazingly versatile tool for the study of mammalian biology.

Babinet C, Cohen-Tannoudji M.

An Acad Bras Cienc. 2001 Sep;73(3):365-83. Review. Erratum in: An Acad Bras Cienc 2001 Dec;73(4):577-80.

8.

Technologically advanced cancer modeling in mice.

Tuveson DA, Jacks T.

Curr Opin Genet Dev. 2002 Feb;12(1):105-10. Review.

PMID:
11790563
9.

Genetically engineered mice as animal models for NIDDM.

Joshi RL, Lamothe B, Bucchini D, Jami J.

FEBS Lett. 1997 Jan 20;401(2-3):99-103. Review.

10.

Mouse genetics/genomics: an effective approach for drug target discovery and validation.

West DB, Iakougova O, Olsson C, Ross D, Ohmen J, Chatterjee A.

Med Res Rev. 2000 May;20(3):216-30. Review.

PMID:
10797467
11.

[Genetically engineered mice and its application to bioindustry].

Koda T, Togashi Y, Nishimura T.

Hokkaido Igaku Zasshi. 2002 Mar;77(2):151-6. Review. Japanese.

PMID:
11968850
12.

Current issues in mouse genome engineering.

Glaser S, Anastassiadis K, Stewart AF.

Nat Genet. 2005 Nov;37(11):1187-93. Review.

PMID:
16254565
13.

Engineering embryonic stem cells with recombinase systems.

SchnĆ¼tgen F, Stewart AF, von Melchner H, Anastassiadis K.

Methods Enzymol. 2006;420:100-36.

PMID:
17161696
14.

Animal transgenesis: an overview.

Gama Sosa MA, De Gasperi R, Elder GA.

Brain Struct Funct. 2010 Mar;214(2-3):91-109. doi: 10.1007/s00429-009-0230-8. Epub 2009 Nov 25. Review.

PMID:
19937345
15.

Modeling cancer in mice.

Jackson-Grusby L.

Oncogene. 2002 Aug 12;21(35):5504-14. Review.

16.

[Gene targeting in embryonic stem cells through homologous recombination].

Takeda N.

Nihon Yakurigaku Zasshi. 2007 May;129(5):330-6. Japanese. No abstract available.

PMID:
17507768
17.

Practical development of genetically engineered animals as human disease models.

Nomura T.

Lab Anim Sci. 1997 Apr;47(2):113-7. Review.

PMID:
9150486
18.

Genetically engineered mouse models for drug discovery: new chemical genetic approaches.

Heck S, Qian X, Velleca M.

Curr Drug Discov Technol. 2004 Jan;1(1):13-26. Review.

PMID:
16472216
19.

Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting.

Murphy BR, Moayedpardazi HS, Gewirtz AM, Diamond SL, Pierce EA.

Gene Ther. 2007 Feb;14(4):304-15. Epub 2006 Oct 5.

PMID:
17024103
20.

BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.

Sparwasser T, Eberl G.

Immunology. 2007 Jul;121(3):308-13. Epub 2007 Apr 16. Review.

Supplemental Content

Support Center